NEW YORK (GenomeWeb) – Sophia Genetics announced today that it has closed a $15 million Series C financing round led by Belgian billionaire Marc Coucke, the founder of Omega Pharma.

The Swiss genetics company will use the funds to add to its line of genomic tests and continue expanding its market, it said in a statement. Sophia added that it has seen a 400 percent growth rate in 2015, led by its analytics platform, Sophia Data Driven Medicine.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.